Trials / Withdrawn
WithdrawnNCT00618293
Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis
Phase 2 Study in Evaluation of the Efficacy and Safety of Haemate HS in This Clinical Setting (Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis)
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Heinrich-Heine University, Duesseldorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of efficacy by determination of transfusion requirements and safety by determination of adverse events in administration of Von Willebrand factor concentrate F VIII (Haemate).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Haemate HS | intravenous infusion of Haemate (dosage dependent on body weight) |
| OTHER | NaCl-solution | intravenous infusion of 0.9%NaCl-Solution |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-07-01
- Completion
- 2011-07-01
- First posted
- 2008-02-20
- Last updated
- 2012-01-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00618293. Inclusion in this directory is not an endorsement.